News
MRVI ▲ +3.4% - Maravai LifeSciences Holdings, Inc.
MRVI ▲ +3.4% - Maravai LifeSciences Holdings, Inc.
$MRVI reported Q3 2026 Adj EPS of -$0.03, beating the -$0.06 estimate by 50.0%. Revenue of $45.9M beat the $43.4M estimate by 5.5%.
04-NOV-2026 04:24 PM ET
Share this post
More filings for $MRVI
MRVI ▲ +2.8% - Maravai LifeSciences Holdings, Inc.Nov 4, 2026MRVI ▼ -0.6% - Maravai LifeSciences Holdings, Inc.Oct 29, 2026MRVI ▲ +0.3% - Maravai LifeSciences Holdings, Inc.Oct 14, 2026MRVI - Maravai LifeSciences Holdings, Inc. - SEC Filing Update (29-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 29, 2026MRVI ▲ +0.3% - Maravai LifeSciences Holdings, Inc.Sep 29, 2026MRVI - Maravai LifeSciences Holdings, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $MRVI filing history →💬 Comments
Loading comments…
Leave a comment